Колоректальный рак

FDA Approves Immunotherapy Regimen Studied by Mayo Clinic for Stage 3 Colon Cancer | Newswise

FDA Approves Immunotherapy Regimen Studied by Mayo Clinic for Stage 3 Colon Cancer | Newswise Newswise

FDA approves immunotherapy regimen studied by Mayo Clinic for stage 3 colon cancer

FDA approves immunotherapy regimen studied by Mayo Clinic for stage 3 colon cancer Mayo Clinic News Network

‘Key’ differences in colorectal cancer with liver metastases

Early-onset colorectal cancer with liver-only metastases can have significant differences in biology from late-onset malignancies. A study of nearly 1,700 individuals from Australia showed early-onset disease occurred more often in women, and patients had higher rates of BRAF mutations and left-sided cancers…

FDA Approves Atezolizumab for Stage III dMMR Colon Cancer After Landmark ATOMIC Trial

FDA Approves Atezolizumab for Stage III dMMR Colon Cancer After Landmark ATOMIC Trial Bioengineer.org

FDA Approves Tecentriq for Stage III dMMR Colon Cancer

FDA Approves Tecentriq for Stage III dMMR Colon Cancer The Clinical Trial Vanguard

FDA approves Tecentriq for stage III colon cancer treatment

FDA approves Tecentriq for stage III colon cancer treatment Investing.com

Alliance announces FDA approval of atezolizumab based on results from the Phase III ATOMIC trial for patients with Stage III dMMR colon cancer

Alliance announces FDA approval of atezolizumab based on results from the Phase III ATOMIC trial for patients with Stage III dMMR colon cancer EurekAlert! Science News Releases

FDA approves Tecentriq for stage III colon cancer treatment By Investing.com

FDA approves Tecentriq for stage III colon cancer treatment By Investing.com Investing.com Nigeria

A drug combo cut recurrence or death risk by 50% in a study. The FDA approved it for a type of stage III colon cancer.

A drug combo cut recurrence or death risk by 50% in a study. The FDA approved it for a type of stage III colon cancer. Stock Titan

FDA Approves Atezolizumab Plus Chemo for Stage 3 dMMR Colon Cancer

FDA Approves Atezolizumab Plus Chemo for Stage 3 dMMR Colon Cancer Oncology Nursing News

FDA Approves Atezolizumab/Chemo for Stage III dMMR/MSI-H Colon Cancer

Colorectal cancer mortality increasing in young adults in Canada

Cancer mortality for individuals aged under 50 years in Canada has significantly decreased for nine of the 10 deadliest malignancies since 2000. “This is a great news story,” Darren R. Brenner, PhD, professor at Cumming School of Medicine at University of Calgary, told Healio. However, colorectal cancer mortality has…

Weight loss helps explain colorectal cancer obesity paradox

Pre-diagnostic weight loss could explain the “obesity paradox” — where patients who have overweight or obesity have improved survival — observed in colorectal cancer. A study of more than 5,500 individuals with colorectal cancer from Germany showed patients who had overweight did have improved survival, but weight…

Metastatic Colorectal Cancer Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 150+ Leading Players Wheeling the Therapeutics Landscape

Metastatic Colorectal Cancer Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 150+ Leading Players Wheeling the Therapeutics Landscape StreetInsider

What Does ERASur’s Global Expansion Mean for Colorectal Cancer Care? - Alliance for Clinical Trials in Oncology

What Does ERASur’s Global Expansion Mean for Colorectal Cancer Care? - Alliance for Clinical Trials in Oncology Oncodaily